Pitfalls Associated with the Use of Liquid Chromatography–Tandem Mass Spectrometry in the Clinical Laboratory
- 1 August 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (8), 1234-1244
- https://doi.org/10.1373/clinchem.2009.138602
Abstract
BACKGROUND: Novel mass spectrometric techniques such as atmospheric pressure ionization and tandem mass spectrometry have substantially extended the spectrum of clinical chemistry methods during the past decade. In particular, liquid chromatography tandem–mass spectrometry (LC-MS/MS) has become a standard tool in research laboratories as well as in many clinical laboratories. Although LC-MS/MS has features that suggest it has a very high analytical accuracy, potential sources of inaccuracy have recently been identified. CONTENT: The sources of inaccuracy in LC-MS/MS methods used in the routine quantification of small molecules are described and discussed. Inaccuracy of LC-MS/MS methods can be related to the process of ionization through the insource transformation of conjugate metabolites or target analytes and may also be attributable to ionization matrix effects that have a differential impact on target analytes and internal-standard compounds. Inaccuracy can also be associated with the process of ion selection, which mainly occurs when compounds from the sample matrix share mass transitions with a target analyte. In individual assays, most potential sources of inaccuracy can be controlled by sufficient LC separation–based sample workup before MS analysis. SUMMARY: LC-MS/MS methods should undergo rigorous and systematic validation before introduction into patient care.Keywords
This publication has 63 references indexed in Scilit:
- Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2009
- Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass SpectrometryClinical Chemistry, 2009
- Feasibility of Ribavirin Therapeutic Drug Monitoring in Hepatitis CTherapeutic Drug Monitoring, 2009
- Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?Clinical Chemistry, 2008
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- Accurate Inclusion Mass ScreeningMolecular & Cellular Proteomics, 2008
- Rapid metabolite identification with sub parts‐per‐million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean‐up on a ZipTip and LTQ/Orbitrap mass spectrometryRapid Communications in Mass Spectrometry, 2008
- Towards a universal product ion mass spectral library – reproducibility of product ion spectra across eleven different mass spectrometersRapid Communications in Mass Spectrometry, 2008
- Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2007
- Peer Reviewed: Scaling MS Plateaus with High-Resolution FT-ICRMSAnalytical Chemistry, 2002